Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by jayjay2020on Sep 20, 2019 2:40pm

97 Views

Post# 30149148

RE:RE:Canadian retail MJ sales by month and APHA

gottahunch wrote: Thank you jayjay. I thought my estimate of 140-150 could possibly be LOW! GLTA

jayjay2020 wrote: Canadian retail sales are as follows by month ( thanks David Cosh for the info )

$41.5M - Oct 18
$53.7M - Nov 18
$57.3M - Dec 18
$54.9M - Jan 19
$51.7M - Feb 19
$60.9M - Mar 19
$74.6M - Apr 19
$85.8M - May 19
$91.5M - Jun 19
$104.5M - Jul 19

https://twitter.com/itsdgc/status/1175034692418048001

IMHO APHA has 10 % of rec sales (possibly more since their sales at OCS have been strong). Therefore APHA should do $30-35M in rec sales for the Q. Adding this to wholesale revenue of $10M and medical revenue of $15M plus CC phama revenue of $100M . My guess revenues for the Q will be a total of $155 -160M. They could reach $170M depending on how much med MJ business they gained from TRST.